AbstractThe present research is the use of Heterocyclic sulfated polysaccharides, exemplified by carrageenan, with the high selective anti‐cancer against melanoma cancer. This study focuses on optimizing the ionic linkage of carrageenan to enhance its selectivity and activity against skin cancer cells with the help of cell line assays and in‐silico studies. The cytotoxicity and selectivity of the optimized derivatives were assessed in‐vitro against skin cancer cells and normal skin cells. The barium‐linked carrageenan demonstrated significantly increased selectivity against skin cancer cells with a selectivity index of 45, however, the reference drug was found with a selectivity index of 23. The selectivity of the compound 3 (Ba ion linked) was analysed through the ion dissociation energy and found that the more energy is require to dissoxiate in the ion, which signifiacnlty absorbs inside the cell because of non‐ionic form. The selectivity sequence of K+<Ca2+<Ba2+ as a targeted anti‐cancer agent. The present research unfold the importance of ion linkage of chromophore, to get the more active and selective compounds, which will be a path to get the ion activity relationship of various drugs without interfering the chromophore. The findings suggest a promising avenue for the development of targeted therapies with the change of ions, emphasizing the potential of heterocyclic sulfated polysaccharides in the field of cancer treatment with enhanced tuning of selectivity. The further scope is the gel formation of the Ba2+ carrageenan which will be the first API (Active Pharmaceuitical Ingredients) based formulation for skin cancer.
Read full abstract